sulfasalazine has been researched along with Enterocolitis, Pseudomembranous in 8 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Enterocolitis, Pseudomembranous: An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neutropenic enterocolitis is a severe complication to cytotoxic therapy for cancer." | 2.41 | [Drug-induced enterocolitis. Important differential diagnosis in the investigation of diarrhea and intestinal hemorrhage]. ( Tysk, C, 2000) |
| "Treatment with sulfasalazine and prednisone resulted in a clinical remission after seven weeks." | 1.29 | [Clostridium difficile in early childhood ulcerative pancolitis]. ( Hoppen, T; Keller, KM; Rister, M; Stolte, M, 1993) |
| "Pseudomembranous colitis is a potentially life-threatening acute medical problem usually associated with a history of previous antibiotic exposure." | 1.26 | Pseudomembranous colitis. A complication of sulfasalazine therapy in a patient with Crohn's colitis. ( Nichols, TW; Pokorney, BH, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugiyama, Y | 1 |
| Ohni, M | 1 |
| Sudoh, N | 1 |
| Mizukawa, S | 1 |
| Akishita, M | 1 |
| Toba, K | 1 |
| Pokorney, BH | 1 |
| Nichols, TW | 1 |
| Hoppen, T | 1 |
| Keller, KM | 1 |
| Stolte, M | 1 |
| Rister, M | 1 |
| Tysk, C | 1 |
| Gupta, R | 1 |
| Sachar, DB | 1 |
| Woodhouse, KW | 1 |
| Marstein, S | 1 |
2 reviews available for sulfasalazine and Enterocolitis, Pseudomembranous
| Article | Year |
|---|---|
[Drug-induced enterocolitis. Important differential diagnosis in the investigation of diarrhea and intestinal hemorrhage].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antirheumatic | 2000 |
Drugs and the ageing gut, liver and pancreas.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Animals; Antacids; Anti-Ulcer Agen | 1985 |
6 other studies available for sulfasalazine and Enterocolitis, Pseudomembranous
| Article | Year |
|---|---|
Recurrent colitis with different causes.
Topics: Aged; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clostridioides difficile; Colitis, U | 2003 |
Pseudomembranous colitis. A complication of sulfasalazine therapy in a patient with Crohn's colitis.
Topics: Adult; Crohn Disease; Enterocolitis, Pseudomembranous; Female; Humans; Sulfasalazine | 1981 |
Sulfasalazine-induced exacerbation of ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Female; Humans; Sulfasalazine | 1982 |
[Clostridium difficile in early childhood ulcerative pancolitis].
Topics: Biopsy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Infant; Intestinal Mucosa; Mal | 1993 |
Chlorpropamide-induced cholestatic jaundice and pseudomembranous colitis.
Topics: Chlorpropamide; Cholestasis; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Male; Middl | 1985 |
[Agranulocytosis during treatment with salicylazosulfapyridine (Salazopyrin)].
Topics: Agranulocytosis; Blood Cell Count; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Sulfa | 1969 |